YOUR PERSONAL BANK PODCAST
with FERENC TOTH
AS HEARD ON…
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a...
Micron’s stock leads the S&P 500 for 2025. Here’s why more gains could follow.
An analyst sees big upside ahead, fueled by rapid growth in high-bandwidth memory for AI.
December jobs report forecast is 155,000. But here’s the number investors really should watch.
Rising unemployment prodded the Federal Reserve to cut interest rates last fall despite lingering inflation — and the jobless rate could still be...